S&D Co. Ltd. (260970) - Cash Flow Conversion Efficiency
Based on the latest financial reports, S&D Co. Ltd. (260970) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.11 Billion ≈ $752.32K USD) by net assets (₩80.00 Billion ≈ $54.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
S&D Co. Ltd. - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how S&D Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read S&D Co. Ltd. total liabilities for a breakdown of total debt and financial obligations.
S&D Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of S&D Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kyongbo Pharmaceutical Co Ltd
KO:214390
|
0.031x |
|
CanAlaska Uranium Ltd
V:CVV
|
-0.078x |
|
Mobile Infrastructure Corporation
NYSE MKT:BEEP
|
0.007x |
|
MagnaChip Semiconductor
NYSE:MX
|
0.001x |
|
Brii Biosciences Limited
F:7SS
|
N/A |
|
Swelect Energy Systems Limited
NSE:SWELECTES
|
0.071x |
|
Fury Gold Mines Ltd
TO:FURY
|
-0.068x |
|
Kewaunee Scientific Corporation
NASDAQ:KEQU
|
-0.059x |
Annual Cash Flow Conversion Efficiency for S&D Co. Ltd. (2016–2024)
The table below shows the annual cash flow conversion efficiency of S&D Co. Ltd. from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see 260970 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩68.06 Billion ≈ $46.12 Million |
₩14.97 Billion ≈ $10.14 Million |
0.220x | +62.74% |
| 2023-12-31 | ₩88.62 Billion ≈ $60.05 Million |
₩11.97 Billion ≈ $8.11 Million |
0.135x | +27.39% |
| 2022-12-31 | ₩78.11 Billion ≈ $52.93 Million |
₩8.28 Billion ≈ $5.61 Million |
0.106x | -21.27% |
| 2021-12-31 | ₩68.95 Billion ≈ $46.73 Million |
₩9.29 Billion ≈ $6.30 Million |
0.135x | -35.61% |
| 2020-12-31 | ₩33.81 Billion ≈ $22.91 Million |
₩7.07 Billion ≈ $4.79 Million |
0.209x | -26.44% |
| 2019-12-31 | ₩26.82 Billion ≈ $18.18 Million |
₩7.63 Billion ≈ $5.17 Million |
0.284x | +4.59% |
| 2018-12-31 | ₩21.15 Billion ≈ $14.33 Million |
₩5.75 Billion ≈ $3.90 Million |
0.272x | +144.56% |
| 2017-12-31 | ₩18.00 Billion ≈ $12.20 Million |
₩2.00 Billion ≈ $1.36 Million |
0.111x | -36.42% |
| 2016-12-31 | ₩14.81 Billion ≈ $10.04 Million |
₩2.59 Billion ≈ $1.76 Million |
0.175x | -- |
About S&D Co. Ltd.
S&D Co., Ltd develops good ingredients and medicare materials in South Korea. The company offers health functional food materials, including Lindera glauca extracts, rice bran extracts, MPG-6/MPGT, RCS, xanthorrhizol, and other materials. It also provides general functional food materials comprising seasoning base/raw materials, miscellaneous, and organic materials. The company was founded in 199… Read more